Most people notice a difference in energy and skin radiance within 4 to 6 weeks of consistent daily use
Official Injection Sites for GLP-1 Medications According to their FDA-approved prescribing information, GLP-1 medications semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) are administered as injections just under the skin (subcutaneous) in three areas: Abdomen avoid the 2 inches (5 cm) directly around the navel Thigh outer/front thigh Upper arm back of the upper arm All four FDA labels (Ozempic 1 , Zepbound 2 , Mounjaro 3 , Wegovy 4 ) explicitly state that patients should rotate injection sites with each dose
If the medication wasnt used within 56 days, it must be disposed of safely, and a new Ozempic pen must be picked up
Patients with a history of pancreatitis or uncontrolled gallstone disease should avoid these therapies
Besides, reduced appetite, anorexia and altered intestinal motility often accompany intestinal inflammation, and might be linked to EEC, since PYY, GLP-1, and CCK signal satiety and modify motility (14, 163, 164)
Tell your health care provider if you have stomach problems that are severe or will not go away
